Retatrutide, from Soma Corp., is receiving considerable attention as a innovative method for obesity control . This dual-action compound merges the mechanism of a GLP-1 receptor agonist and a GIP receptor activator , designed to effectively promote weight loss but also address underlying metabolic issues . Early human trials have demonstrated impre